Brief: Nuvectis Pharma Inc Reports Q2 Loss Per Share Of $0.28
05/08/2022 13:36
Aug 5 (Reuters) - Nuvectis Pharma Inc NVCT.O :
* NUVECTIS PHARMA, INC. REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
* NUVECTIS PHARMA INC - QTRLY LOSS PER SHARE $0.28
Source text for Eikon: ID:nGNX9fBK3q
Further company coverage: NVCT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Nuvectis Pharma
See all newsNuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Nuvectis Pharma Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Ciprocopan (NXP100) Receives Marketing Approval In China For The Treatment Of Patients With PNH Previously Untreated With Complement Inhibitors
U.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin